Annual Shareholders Equity
$429.17 M
+$102.97 M+31.57%
31 December 2023
Summary:
Celldex Therapeutics annual stockholders equity is currently $429.17 million, with the most recent change of +$102.97 million (+31.57%) on 31 December 2023. During the last 3 years, it has risen by +$219.81 million (+104.99%). CLDX annual shareholders equity is now at all-time high.CLDX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$785.90 M
-$27.75 M-3.41%
01 September 2024
Summary:
Celldex Therapeutics quarterly stockholders equity is currently $785.90 million, with the most recent change of -$27.75 million (-3.41%) on 01 September 2024. Over the past year, it has increased by +$539.19 million (+218.54%). CLDX quarterly shareholders equity is now -6.29% below its all-time high of $838.61 million, reached on 31 March 2024.CLDX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLDX Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +31.6% | +218.5% |
| 3 y3 years | +105.0% | +80.0% |
| 5 y5 years | +245.9% | +675.2% |
CLDX Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +105.0% | -6.3% | +218.5% |
| 5 y | 5 years | at high | +356.4% | -6.3% | +838.9% |
| alltime | all time | at high | >+9999.0% | -6.3% | +5735.1% |
Celldex Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $785.90 M(-3.4%) |
| June 2024 | - | $813.66 M(-3.0%) |
| Mar 2024 | - | $838.61 M(+95.4%) |
| Dec 2023 | $429.17 M(+31.6%) | $429.17 M(+74.0%) |
| Sept 2023 | - | $246.72 M(-11.1%) |
| June 2023 | - | $277.54 M(-8.3%) |
| Mar 2023 | - | $302.74 M(-7.2%) |
| Dec 2022 | $326.20 M(-22.2%) | $326.20 M(-5.6%) |
| Sept 2022 | - | $345.42 M(-5.4%) |
| June 2022 | - | $365.09 M(-8.3%) |
| Mar 2022 | - | $398.10 M(-5.1%) |
| Dec 2021 | $419.48 M(+100.4%) | $419.48 M(-3.9%) |
| Sept 2021 | - | $436.71 M(+139.6%) |
| June 2021 | - | $182.28 M(-6.1%) |
| Mar 2021 | - | $194.17 M(-7.3%) |
| Dec 2020 | $209.36 M(+122.7%) | $209.36 M(-9.0%) |
| Sept 2020 | - | $229.97 M(-3.6%) |
| June 2020 | - | $238.44 M(+184.9%) |
| Mar 2020 | - | $83.70 M(-11.0%) |
| Dec 2019 | $94.03 M(-24.2%) | $94.03 M(-7.3%) |
| Sept 2019 | - | $101.38 M(-7.5%) |
| June 2019 | - | $109.63 M(-2.7%) |
| Mar 2019 | - | $112.69 M(-9.2%) |
| Dec 2018 | $124.06 M(-47.5%) | $124.06 M(-3.2%) |
| Sept 2018 | - | $128.13 M(+0.1%) |
| June 2018 | - | $128.05 M(-4.5%) |
| Mar 2018 | - | $134.08 M(-43.3%) |
| Dec 2017 | $236.37 M(-10.9%) | $236.37 M(+7.9%) |
| Sept 2017 | - | $219.15 M(-5.3%) |
| June 2017 | - | $231.46 M(-6.6%) |
| Mar 2017 | - | $247.84 M(-6.6%) |
| Dec 2016 | $265.43 M(-8.5%) | $265.43 M(+22.3%) |
| Sept 2016 | - | $217.09 M(-7.5%) |
| June 2016 | - | $234.71 M(-9.7%) |
| Mar 2016 | - | $260.03 M(-10.4%) |
| Dec 2015 | $290.11 M(+37.1%) | $290.11 M(-9.0%) |
| Sept 2015 | - | $318.63 M(-7.9%) |
| June 2015 | - | $345.88 M(-7.9%) |
| Mar 2015 | - | $375.55 M(+77.4%) |
| Dec 2014 | $211.66 M(-33.8%) | $211.66 M(-11.6%) |
| Sept 2014 | - | $239.37 M(-9.8%) |
| June 2014 | - | $265.31 M(-9.1%) |
| Mar 2014 | - | $291.85 M(-8.7%) |
| Dec 2013 | $319.80 M(+233.9%) | $319.80 M(+104.0%) |
| Sept 2013 | - | $156.75 M(-11.5%) |
| June 2013 | - | $177.09 M(-9.2%) |
| Mar 2013 | - | $194.94 M(+103.5%) |
| Dec 2012 | $95.77 M(+39.4%) | $95.77 M(+5.2%) |
| Sept 2012 | - | $91.02 M(-3.7%) |
| June 2012 | - | $94.55 M(-12.4%) |
| Mar 2012 | - | $107.89 M(+57.0%) |
| Dec 2011 | $68.72 M(-8.7%) | $68.72 M(-14.8%) |
| Sept 2011 | - | $80.67 M(-12.3%) |
| June 2011 | - | $92.00 M(+39.9%) |
| Mar 2011 | - | $65.78 M(-12.6%) |
| Dec 2010 | $75.25 M(+2.0%) | $75.25 M(+44.7%) |
| Sept 2010 | - | $52.02 M(-13.3%) |
| June 2010 | - | $60.00 M(-12.4%) |
| Mar 2010 | - | $68.46 M(-7.2%) |
| Dec 2009 | $73.77 M(+306.8%) | $73.77 M(-3393.2%) |
| Sept 2009 | - | -$2.24 M(-152.1%) |
| June 2009 | - | $4.30 M(-63.5%) |
| Mar 2009 | - | $11.79 M(-35.0%) |
| Dec 2008 | $18.13 M(-1702.1%) | $18.13 M(-23.9%) |
| Sept 2008 | - | $23.84 M(-19.0%) |
| June 2008 | - | $29.43 M(+4.5%) |
| Mar 2008 | - | $28.16 M(-2588.1%) |
| Dec 2007 | -$1.13 M(-152.4%) | -$1.13 M(-91.9%) |
| Sept 2007 | - | -$13.95 M(+57.9%) |
| June 2007 | - | -$8.83 M(+162.5%) |
| Mar 2007 | - | -$3.36 M(-255.7%) |
| Dec 2006 | $2.16 M | $2.16 M(-71.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2006 | - | $7.70 M(-39.8%) |
| June 2006 | - | $12.80 M(-29.6%) |
| Mar 2006 | - | $18.19 M(-12.9%) |
| Dec 2005 | $20.89 M(-45.6%) | $20.89 M(-15.4%) |
| Sept 2005 | - | $24.69 M(-15.0%) |
| June 2005 | - | $29.05 M(-13.7%) |
| Mar 2005 | - | $33.66 M(-12.4%) |
| Dec 2004 | $38.41 M(+37.6%) | $38.41 M(-8.5%) |
| Sept 2004 | - | $41.98 M(-7.9%) |
| June 2004 | - | $45.57 M(-7.7%) |
| Mar 2004 | - | $49.39 M(+76.9%) |
| Dec 2003 | $27.92 M(-10.9%) | $27.92 M(-12.5%) |
| Sept 2003 | - | $31.92 M(+29.2%) |
| June 2003 | - | $24.71 M(-11.4%) |
| Mar 2003 | - | $27.90 M(-11.0%) |
| Dec 2002 | $31.34 M(-30.8%) | $31.34 M(-10.2%) |
| Sept 2002 | - | $34.91 M(-0.9%) |
| June 2002 | - | $35.23 M(-12.8%) |
| Mar 2002 | - | $40.39 M(-10.8%) |
| Dec 2001 | $45.27 M(-16.1%) | $45.27 M(+17.5%) |
| Sept 2001 | - | $38.54 M(-13.8%) |
| June 2001 | - | $44.71 M(-11.0%) |
| Mar 2001 | - | $50.22 M(-6.9%) |
| Dec 2000 | $53.93 M(+209.7%) | $53.93 M(+12.1%) |
| Sept 2000 | - | $48.10 M(+188.9%) |
| June 2000 | - | $16.65 M(-13.0%) |
| Mar 2000 | - | $19.14 M(+9.9%) |
| Dec 1999 | $17.41 M(-7.4%) | $17.41 M(-17.1%) |
| Sept 1999 | - | $21.00 M(+53.3%) |
| June 1999 | - | $13.70 M(-14.4%) |
| Mar 1999 | - | $16.00 M(-14.9%) |
| Dec 1998 | $18.80 M(+198.4%) | $18.80 M(-10.9%) |
| Sept 1998 | - | $21.10 M(+197.2%) |
| June 1998 | - | $7.10 M(-17.4%) |
| Mar 1998 | - | $8.60 M(+36.5%) |
| Dec 1997 | $6.30 M(-59.6%) | $6.30 M(-18.2%) |
| Sept 1997 | - | $7.70 M(-35.8%) |
| June 1997 | - | $12.00 M(-12.4%) |
| Mar 1997 | - | $13.70 M(-12.2%) |
| Dec 1996 | $15.60 M(-2.5%) | $15.60 M(-13.3%) |
| Sept 1996 | - | $18.00 M(+76.5%) |
| June 1996 | - | $10.20 M(-28.2%) |
| Mar 1996 | - | $14.20 M(-11.3%) |
| Dec 1995 | $16.00 M(-9.1%) | $16.00 M(+64.9%) |
| Sept 1995 | - | $9.70 M(-23.0%) |
| June 1995 | - | $12.60 M(-17.1%) |
| Mar 1995 | - | $15.20 M(-13.6%) |
| Dec 1994 | $17.60 M(-39.5%) | $17.60 M(-15.4%) |
| Sept 1994 | - | $20.80 M(-12.2%) |
| June 1994 | - | $23.70 M(-10.6%) |
| Mar 1994 | - | $26.50 M(-8.9%) |
| Dec 1993 | $29.10 M(+47.7%) | $29.10 M(+103.5%) |
| Sept 1993 | - | $14.30 M(-14.4%) |
| June 1993 | - | $16.70 M(-8.2%) |
| Mar 1993 | - | $18.20 M(-12.9%) |
| Dec 1992 | $19.70 M(-14.7%) | - |
| Oct 1992 | - | $20.90 M(-5.0%) |
| July 1992 | - | $22.00 M(-4.8%) |
| Apr 1992 | - | $23.10 M(-6.1%) |
| Apr 1992 | $23.10 M(+122.1%) | - |
| Jan 1992 | - | $24.60 M(-0.8%) |
| Oct 1991 | - | $24.80 M(-5.7%) |
| July 1991 | - | $26.30 M(+152.9%) |
| Apr 1991 | $10.40 M(-20.6%) | $10.40 M(-1.9%) |
| Jan 1991 | - | $10.60 M(-7.0%) |
| Oct 1990 | - | $11.40 M(-5.8%) |
| July 1990 | - | $12.10 M(-7.6%) |
| Apr 1990 | $13.10 M(+56.0%) | $13.10 M(+32.3%) |
| Jan 1990 | - | $9.90 M(+17.9%) |
| Apr 1989 | $8.40 M(-9.7%) | $8.40 M(-9.7%) |
| Apr 1988 | $9.30 M(-10.6%) | $9.30 M(-10.6%) |
| Apr 1987 | $10.40 M(-516.0%) | $10.40 M(-516.0%) |
| Apr 1986 | -$2.50 M | -$2.50 M |
FAQ
- What is Celldex Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Celldex Therapeutics?
- What is Celldex Therapeutics annual shareholders equity year-on-year change?
- What is Celldex Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly shareholders equity year-on-year change?
What is Celldex Therapeutics annual stockholders equity?
The current annual shareholders equity of CLDX is $429.17 M
What is the all time high annual shareholders equity for Celldex Therapeutics?
Celldex Therapeutics all-time high annual stockholders equity is $429.17 M
What is Celldex Therapeutics annual shareholders equity year-on-year change?
Over the past year, CLDX annual stockholders equity has changed by +$102.97 M (+31.57%)
What is Celldex Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of CLDX is $785.90 M
What is the all time high quarterly shareholders equity for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly stockholders equity is $838.61 M
What is Celldex Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, CLDX quarterly stockholders equity has changed by +$539.19 M (+218.54%)